167 related articles for article (PubMed ID: 33127935)
1. Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy.
Watanabe T; Nanamiya H; Kojima M; Nomura S; Furukawa S; Soeda S; Tanaka D; Isogai T; Imai JI; Watanabe S; Fujimori K
Sci Rep; 2020 Oct; 10(1):18734. PubMed ID: 33127935
[TBL] [Abstract][Full Text] [Related]
2. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
[TBL] [Abstract][Full Text] [Related]
4. Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.
Spaans VM; Trietsch MD; Peters AA; Osse M; Ter Haar N; Fleuren GJ; Jordanova ES
PLoS One; 2015; 10(7):e0133670. PubMed ID: 26197069
[TBL] [Abstract][Full Text] [Related]
5. ERBB2 mutation: A promising target in non-squamous cervical cancer.
Xiang L; Jiang W; Ye S; He T; Pei X; Li J; Chan DW; Ngan HYS; Li F; Tao P; Shen X; Zhou X; Wu X; Yang G; Yang H
Gynecol Oncol; 2018 Feb; 148(2):311-316. PubMed ID: 29279289
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
7. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
8. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
[TBL] [Abstract][Full Text] [Related]
9. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
10. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
11. Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.
Murakami N; Asami Y; Yoshida H; Takayanagi D; Hirose S; Kuno I; Takahashi K; Matsuda M; Shimada Y; Yamano S; Sunami K; Honda T; Nakahara T; Watanabe T; Okuma K; Kuroda T; Kohno T; Kato T; Shiraishi K; Itami J
Sci Rep; 2021 May; 11(1):10567. PubMed ID: 34012039
[TBL] [Abstract][Full Text] [Related]
12. Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
Sclafani F; Wilson SH; Cunningham D; Gonzalez De Castro D; Kalaitzaki E; Begum R; Wotherspoon A; Capdevila J; Glimelius B; Roselló S; Thomas J; Tait D; Brown G; Oates J; Chau I
Int J Cancer; 2020 Jan; 146(1):94-102. PubMed ID: 31199501
[TBL] [Abstract][Full Text] [Related]
13. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
[TBL] [Abstract][Full Text] [Related]
15. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
16. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
[TBL] [Abstract][Full Text] [Related]
17. [Lymphatic mapping and parametrial lymph nodes identification in patients with early stage cervical cancer].
Li B; Wu LY; Li XG; Zhang X; Zhang WH; Gao JZ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):608-11. PubMed ID: 17181971
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
19. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]